CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 22 enrolled
Drug / intervention
Norco 5milligram-325milligram Tablet +1 moredrug
Likely dose
Norco 5milligram-325milligram Tabletfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03872843
NCT03872843Phase 4Completed

A Prospective Double Blind Randomized Control Trial Comparing Opioid to Non-Opioid Protocol in Managing Postoperative Pain After Ureteroscopy With Stent Placement

Wake Forest University Health Sciences·interventional·Posted Mar 13, 2019·Updated Mar 11, 2021

In Brief

A Phase 4 clinical trial evaluating Norco 5milligram-325milligram Tablet and Ibuprofen 400 MILLIGRAM in 1 TABLET ORAL TABLET, FILM COATED for Kidney Stone. Completed, enrolled 22 participants across 1 site.

Detailed Summary

The purpose of this research study is to compare how well two medications work to control post-operative pain.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsKidney Stone
CountriesUnited States
Collaborators--

Timeline

Phase 4CompletedFinished
20192020202120222023202420252026
First PostedMar 13, 2019
Enrollment StartSep 19, 2019
Primary CompletionFeb 26, 2020
TodayJul 2, 2026
Enrollment to primary: 5 monthsPosted 7.3 years ago

Interventions

Norco 5milligram-325milligram Tabletdrug

Designated coated 7 days supply of pain medication (Norco 5 milligram-325milligram Tablet) will be sent home with discharged subjects. Pain medication is administered/scheduled 4 times per day until the stent will be removed in clinic a week later.

Ibuprofen 400 MILLIGRAM in 1 TABLET ORAL TABLET, FILM COATEDdrug

Designated coated 7 days supply of pain medication (Ibuprofen 400 milligram) will be sent home with discharged subjects. Pain medication is administered/scheduled 4 times a day as needed until the stent will be removed in clinic a week later.